Z-2692-2014 Class II Terminated
FDA device recall Z-2692-2014 was initiated by Horiba Instruments, Inc Dba Horiba Medical on Aug 11, 2014 and is designated Class II. Reason for recall: Horiba Medical is recalling the ABX PENTRA Magnesium RTU Reagent because the on-board stability claims has been updated. Horiba has updated the ABX PENTRA Magnesium RTU package inserts by removing… The recall status is terminated (terminated Nov 25, 2014). Affected quantity: 359 units.
Recall details
- Product Type
- Devices
- Report Date
- Oct 1, 2014
- Initiation Date
- Aug 11, 2014
- Termination Date
- Nov 25, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 359 units
Product description
ABX PENTRA Magnesium RTU Reagent, Part No. A11A01646 Product Usage: ABX PENTRA Magnesium RTU reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of magnesium in human serum and plasma based on a photometric test using xylidyl blue. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemnia (abnormally low plasma levels of magnesium) and hypermagnesemnia (abnormally high plasma levels of magnesium).
Reason for recall
Horiba Medical is recalling the ABX PENTRA Magnesium RTU Reagent because the on-board stability claims has been updated. Horiba has updated the ABX PENTRA Magnesium RTU package inserts by removing the 7-day on-board stability claim and replacing it with a 1-day on-board stability claim.
Distribution pattern
US Nationwide Distribution.
Code information
All Lots
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2692-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026